Mucoid strains of Pseudomonas aeruginosa cause chronic infections in the lungs of cystic fibrosis patients and are the major cause of morbidity and death in these patients. The production of large amounts of the exoplysaccharide, often call alginate, is responsible for the mucoid colony morphology of these strains. The molecular mechanism responsible for the conversion of nonmucoid strains of P. aeruginosa to those with a mucoid phenotype is unknown. One goal of this proposal is to identify the molecular genetic basis for the activation of alginate production. This will be accomplished by determining the DNA sequence differences between cloned alginate conversion genes, known as algS(On) and algS(Off), from mucoid and nonmucoid cells. Comparison of algS from clinical and environmental isolates utilizing the polymerase chain reaction will indicate whether the genetic mechanism of alginate conversion is conserved. The DNA sequence, transcriptional start site, and the inferred amino acid homology of the adjacent alginate gene, algT, will be determined. Another goal of this proposal is to ascertain the role of environmental factors in the conversion of nonmucoid strains to the mucoid phenotype. A promoterless antiotic resistance """"""""reporter"""""""" gene will be cloned into the alginate algT gene to make an algT transcriptional fusion. Induction and regulation of alginate conversion will be selected for in strains containing the algT fusion by resistance to antibiotics. These algT fusions will be examined in various genetic backgrounds and under various growth conditions determine those factors influencing alginate conversion. This proposal will also assess the role of alginate in the pathogenesis of P. aeruginosa infections. By introduction of the cloned alginate conversion genes into P. aeruginosa infections. By introduction of the cloned alginate conversion genes into P. aeruginosa strains with varying lipopolysaccharide structure, mucoid derivatives of these strains, which differ only in the production of alginate, will be constructed. These isogenic strains will be compared to determine the relative contribution of alginate and lipopolysaccharide to immunity, in both in vitro opsonic-killing assays in vivo protection assays in animal models. These comparisons will shed light on the immunity specific for lipopolysaccharide and alginate. The combination of a molecular genetic approach to study the production of alginate and an immunological characterization of this exopolysaccharide should provide important insights into the regulation of this important virulence factor in P. aeruginosa.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29AI030050-04
Application #
2065405
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Project Start
1991-08-01
Project End
1996-05-31
Budget Start
1994-06-01
Budget End
1995-05-31
Support Year
4
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Jacobson, Alan R; Adler, Michael; Silvaggi, Nicholas R et al. (2017) Small molecule metalloprotease inhibitor with in vitro, ex vivo and in vivo efficacy against botulinum neurotoxin serotype A. Toxicon 137:36-47
Sponseller, Jerlyn K; Steele, Jennifer A; Schmidt, Diane J et al. (2015) Hyperimmune bovine colostrum as a novel therapy to combat Clostridium difficile infection. J Infect Dis 211:1334-41
Yang, Zhiyong; Schmidt, Diane; Liu, Weilong et al. (2014) A novel multivalent, single-domain antibody targeting TcdA and TcdB prevents fulminant Clostridium difficile infection in mice. J Infect Dis 210:964-72
Jeong, Kwang-Il; Venkatesan, Malabi M; Barnoy, Shoshana et al. (2013) Evaluation of virulent and live Shigella sonnei vaccine candidates in a gnotobiotic piglet model. Vaccine 31:4039-46
Steele, Jennifer; Zhang, Quanshun; Beamer, Gillian et al. (2013) MBX-500 is effective for treatment of Clostridium difficile infection in gnotobiotic piglets. Antimicrob Agents Chemother 57:4039-41
Pieper, Rembert; Fisher, C R; Suh, Moo-Jin et al. (2013) Analysis of the proteome of intracellular Shigella flexneri reveals pathways important for intracellular growth. Infect Immun 81:4635-48
Silhár, Peter; Lardy, Matthew A; Hixon, Mark S et al. (2013) The C-terminus of Botulinum A Protease Has Profound and Unanticipated Kinetic Consequences Upon the Catalytic Cleft. ACS Med Chem Lett 4:283-287
Shoemaker, Charles B; Oyler, George A (2013) Persistence of Botulinum neurotoxin inactivation of nerve function. Curr Top Microbiol Immunol 364:179-96
Steele, Jennifer; Mukherjee, Jean; Parry, Nicola et al. (2013) Antibody against TcdB, but not TcdA, prevents development of gastrointestinal and systemic Clostridium difficile disease. J Infect Dis 207:323-30
Pieper, Rembert; Zhang, Quanshun; Clark, David J et al. (2013) Proteomic View of Interactions of Shiga Toxin-Producing Escherichia coli with the Intestinal Environment in Gnotobiotic Piglets. PLoS One 8:e66462

Showing the most recent 10 out of 83 publications